Graalum

Norway

36 total trials 18 recruiting

Filter these 36 trials by phase, condition, sponsor and more.

Open in Search →

A double-blind randomized placebo-controlled four-arm trial to assess the efficacy of oral bicarbonate and intravenous butylscopolamine brom … Ended recruitment

2024-511848-55-00 5 2023-01-03 childbirth
An Open-label, Randomized Phase 3 Study of Immune and Targeted Combination Therapies, as First-line Treatment in Participants with Advanced … Ended recruitment

2022-502122-41-00 5 2021-05-11 Clear cell renal cancer
POLAR BEAR Ended recruitment

2022-502887-19-00 5 2020-08-18 Diffuse Large B-Cell Lymphoma
Efficacy Study of Nivolumab Compared to Placebo in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIB/C Melanoma (Ch … Ended recruitment

2022-502354-14-00 5 2019-10-28 Completely resected Stage IIb/c melanoma
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran … Ended

2023-503793-20-00 5 2023-01-18 Prevention of ischemic stroke in patients post acute non-cardioembolic
A Phase IIa Study to assess Safety, Tolerability, and Pharmacodynamics of AZD4831 in Adult Participants with Non-cirrhotic NASH with Fibrosi … Ended

2022-500594-13-00 4 2022-12-14 "Non-Alcoholic Steatohepatatis (NASH) is the progressive form of Non-A
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis … Ended

2023-503794-38-00 5 2022-11-24 Prevention of stroke or systemic embolism in atrial fibrillation
Efficacy and Safety of AXL-Inhibitor bemcentinib for the Treatment of Moderate COVID-19 (AXL-SolidAct) Ended

2022-500363-12-00 4 2022-08-24 SARS CoV-2 (COVID-19)
Cohort study of human mpox virus disease Ended

2022-501132-42-00 6 2022-08-02 Monkeypox virus disease
PARASTOP - Paracetamol with Strong Opioids Ended

2024-515012-53-00 5 2021-10-20 Metastatic cancer disease
European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial (SolidAct) Ended

2022-500385-99-00 5 2021-06-03 SARS-CoV II infection (Coronavirus disease)
A study of Chemo only versus Chemo plus Nivo with or without BMS986205, Followed by Post- Surgery Therapy with Nivo or Nivo and BMS986205 in … Ended

2024-512158-12-00 5 2018-12-14 Bladder Cancer Muscle-Invasive Bladder Cancer

Showing 25–36 of 36 trials